These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6794193)

  • 1. Freezing red blood cells prepared for quality control of antiglobulin sera.
    Szymanski IO; Harper JM; Odgren PR; Valeri CR
    Transfusion; 1981; 21(5):498-501. PubMed ID: 6794193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significance of red cell bound complement components in development of standards and quality assurance for the anti-complement components of antiglobulin sera.
    Garratty G; Petz LD
    Transfusion; 1976; 16(4):297-306. PubMed ID: 951725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between the third component of human complement (C3) bound to stored preserved erythrocytes and their viability in vivo.
    Szymanski IO; Odgren PR; Valeri CR
    Vox Sang; 1985; 49(1):34-41. PubMed ID: 4013142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the preservation of red blood cells. Attachment of the third component of human complement to erythrocytes during storage at 4 degrees C.
    Szymanski IO; Odgren PR
    Vox Sang; 1979; 36(4):213-24. PubMed ID: 462911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of fragments of the third component of human complement on erythrocytes by a new immunochemical method.
    Szymanski IO; Odgren PR
    Vox Sang; 1984; 46(2):92-101. PubMed ID: 6608178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic determinants of C3 and C4 complement components on washed erythrocytes from normal persons.
    Rosenfield RE; Jagathambal
    Transfusion; 1978; 18(5):517-23. PubMed ID: 81545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement and Ig uptake by erythrocytes in low ionic strength solutions.
    Szymanski IO; Keegan MG; Odgren PR
    Vox Sang; 1981 Sep; 41(3):151-9. PubMed ID: 6800132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of complement binding by anti-D and anti-M antibodies employing labelled antiglobulin antibodies.
    Freedman J; Massey A; Chaplin H; Monroe MC
    Br J Haematol; 1980 Jun; 45(2):309-18. PubMed ID: 6776980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparisons of pooled polyclonal rabbit anti-human C3d with four monoclonal mouse anti-human C3ds. II. Quantitation of RBC-bound C3d, and characterization of antiglobulin agglutination reactions against RBC from 27 patients with autoimmune hemolytic anemia.
    Chaplin H; Monroe MC
    Vox Sang; 1986; 50(2):87-93. PubMed ID: 2421484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid method for the production of erythrocytes in the state "EC4" and "EC43".
    Jenkins DE; Moore WH; Luthringer DG; Johnson RM
    Transfusion; 1975; 15(5):402-7. PubMed ID: 812218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serologic comparison of a monoclonal anti-C3d with commercial antiglobulin reagents.
    Barker JM
    Transfusion; 1982; 22(6):507-10. PubMed ID: 6983162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weak "false positive" direct antiglobulin test reactions with polyspecific antiglobulin reagents: lack of correlation with red-blood-cell-bound C3d.
    Nasongkla M; Hummert J; Chaplin H
    Transfusion; 1982; 22(4):273-5. PubMed ID: 6980507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproducible in vitro preparation of intermediate C3d coated red blood cells.
    Hoffman NL; Monroe MC; Chaplin H
    Transfusion; 1982; 22(3):180-4. PubMed ID: 7046159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A trypsin method for coating human red blood cells with plasma C3 and/or C4.
    Hsu TC; Steinberg J; Borley RJ; Sawitsky A
    Transfusion; 1980; 20(4):471-3. PubMed ID: 6967638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and use of the C3d subunit C3.
    Moore JA; Michael JM; Chaplin H
    Transfusion; 1976; 16(3):200-8. PubMed ID: 1084603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red blood cell-bound C3d in normal subjects and in random hospital patients.
    Freedman J; Barefoot C
    Transfusion; 1982; 22(6):511-4. PubMed ID: 6216637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of supernatant osmolality and supernatant refraction to assess the glycerol concentration in glycerolized and deglycerolized previously frozen RBC.
    Robert Valeri C; Ragno G
    Transfus Apher Sci; 2007 Apr; 36(2):133-7. PubMed ID: 17376744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement components detected on normal red blood cells taken into EDTA and CPD.
    Freedman J; Massey A
    Vox Sang; 1979; 37(1):1-8. PubMed ID: 115154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo instability of red-blood-cell-bound C3d and C4d.
    Chaplin H; Coleman ME; Monroe MC
    Blood; 1983 Nov; 62(5):965-71. PubMed ID: 6605168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunoassay evaluation of anti-C3d reactivity in broad spectrum commercial antiglobulin reagents.
    Chaplin H; Hoffmann NL
    Transfusion; 1982; 22(1):6-11. PubMed ID: 6977899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.